FT Health: Communicable Diseases

The year-old outbreak of Ebola in DRC underlines the urgent need for new approaches to the threat of epidemic disease. FT writers examine the latest thinking from industry and public health authorities

© John Wessels/FT

New vaccine from J&J could supplement current shot from Merck

Experts counter vaccine fears with tragic tales of people who suffered from preventable diseases

Cepi’s Richard Hatchett outlines the economic case for investing in vaccines

Market failure gives little incentive to develop new drugs as antimicrobial resistance grows

Primary care practices best placed to monitor immunisation and disease

The non-profit pairs Japanese pharma with global organisations to tackle disease in low-income countries

New system will also help country fight threat of disease at home